Related Experiment Videos
Cardiovascular risk is increased in patients with Paget's disease of bone: Insights from the CARTaGENE cohort
Catherine Champagne1, Clément Vachey2, Aurélie Dufour2
1Faculty of Medicine, Department of Medicine, Université Laval, Quebec, QC, Canada.
Insights
Paget's disease of bone (PD) is linked to a higher risk of major adverse cardiovascular events (MACE) in middle-aged adults. However, Paget's disease did not show a significant association with arterial stiffness in this study.
Area of Science:
- Cardiology
- Endocrinology
- Rheumatology
Background:
- Paget's disease of bone (PD) is a chronic condition affecting bone metabolism.
- The potential cardiovascular implications of PD, including major adverse cardiovascular events (MACE) and arterial stiffness, require further investigation.
Purpose of the Study:
- To determine if Paget's disease of bone increases the risk of MACE.
- To assess the association between PD and arterial stiffness in middle-aged individuals.
Main Methods:
- Analysis of the CARTaGENE cohort (n=19,990) aged 40-69 years, linked to healthcare administrative databases.
- Inclusion of PD diagnosis and MACE data from 1997-2021, with comorbidities and arterial stiffness measured at recruitment.
- Propensity-score matching (1:3) and time-to-event analyses using Cox and Fine-Gray models were employed.
Main Results:
- 101 participants (0.5%) had PD; they were older and had higher diabetes prevalence.
- PD was associated with a significantly increased risk for MACE-3 (HR 1.86) and MACE-5 (HR 2.06).
- No significant associations were found between PD and arterial stiffness parameters (augmentation index, estimated pulse wave velocity).
Conclusions:
- Paget's disease of bone is an independent risk factor for major adverse cardiovascular events.
- Paget's disease of bone is not significantly associated with arterial stiffness.
Introduction:
We aimed to assess whether Paget's disease of bone (PD) increases the risk of major adverse cardiovascular events (MACE) and arterial stiffness in middle-aged men and women.
Methods:
We analyzed data from the CARTaGENE cohort, including individuals aged 40-69 years, recruited in the province of Quebec, Canada in 2009/2010, linked to healthcare administrative databases to identify PD and MACE (both before and after recruitment, 1997-2021). Comorbidities and arterial stiffness parameters (augmentation index, estimated pulse wave velocity) were measured at recruitment. Cardiovascular risk factors were compared in an age-standardized population. MACE was defined as 3-component (myocardial infarction, stroke, cardiovascular death) or 5- component (3-point + heart failure, unstable angina) variables. Time-to-event analyses (from birth) used Cox and Fine-Gray models in a 1:3 propensity-score matched population, and associations with arterial stiffness were tested with linear and logistic regressions.
Results:
Among 19,990 participants, 101 (0.5%) had PD. PD participants were older (57.5 ± 7.7 vs 54.2 ± 7.9 years) and had a higher prevalence of diabetes (22.4% vs 9.9%) than participants without PD. Ten (10%) MACE-3 and 15 (15%) MACE-5 occurred in the PD group versus 18 (6%) and 24 (8%) in the matched sample (n = 303). Hazard ratios were 1.86 (95%CI 0.80-4.34) for MACE-3 and 2.06 (95%CI 1.06-4.04) for MACE-5. Competing risk models yielded similar results. No significant associations were observed with arterial stiffness parameters.
Conclusion:
PD was associated with an independently increased risk of MACE, but not with arterial stiffness.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Coronary Artery Disease II: Pathophysiology
Osteoclasts in Bone Remodeling
Coronary Artery Disease I: Introduction
Peripheral Artery Disease I: Introduction